ABEO 8-K: SEC filing
Abeona Therapeutics
Filed with the SEC on · accession 0001493152-26-050609
ABEO filed a 8-K (current report) with the SEC on Nov 9, 2026. Abeona Therapeutics issued a press release reporting its financial results for the quarter ended September 30, 2026, and also furnished an investor presentation.
Summary of the filing
Abeona Therapeutics issued a press release reporting its financial results for the quarter ended September 30, 2026, and also furnished an investor presentation. The filing is a routine earnings disclosure under Item 2.02 and Regulation FD disclosure under Item 7.01.
Key details
✦ Ask GOAX AI about this filing — what it means for ABEO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ABEO?
Click hereFrequently asked questions
What did ABEO file with the SEC on Nov 9, 2026?
ABEO filed a 8-K (SEC filing). Abeona Therapeutics issued a press release reporting its financial results for the quarter ended September 30, 2026, and also furnished an investor presentation. The filing is a routine earnings disclosure under Item 2.02 and Regulation FD disclosure under Item 7.01.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other ABEO SEC filings
- SCHEDULE 13D · Activist campaignOct 23, 2026
- 8-K · SEC filingSep 15, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 13, 2026
- 10-Q · Material agreementAug 13, 2026
- 424B3 · Secondary offeringJul 10, 2026
- 8-K · Board changeJun 12, 2026
- 8-K · Board changeJun 12, 2026
- 8-K · Regulatory actionJun 4, 2026
- 10-Q · SEC filingMay 13, 2026
Get alerts when ABEO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days